- Home
- ACXP vs KNW Comparison
ACXP vs KNW Comparison
Compare ACXP & KNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- KNW
- Stock Information
- Founded
- ACXP 2017
- KNW 1998
- Country
- ACXP United States
- KNW United States
- Employees
- ACXP N/A
- KNW N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- KNW Industrial Machinery/Components
- Sector
- ACXP Health Care
- KNW Industrials
- Exchange
- ACXP Nasdaq
- KNW Nasdaq
- Market Cap
- ACXP 32.0M
- KNW 28.6M
- IPO Year
- ACXP 2021
- KNW N/A
- Fundamental
- Price
- ACXP $1.96
- KNW $0.19
- Analyst Decision
- ACXP Strong Buy
- KNW Buy
- Analyst Count
- ACXP 1
- KNW 1
- Target Price
- ACXP $12.00
- KNW $1.00
- AVG Volume (30 Days)
- ACXP 40.2K
- KNW 413.8K
- Earning Date
- ACXP 11-13-2024
- KNW 12-17-2024
- Dividend Yield
- ACXP N/A
- KNW N/A
- EPS Growth
- ACXP N/A
- KNW N/A
- EPS
- ACXP N/A
- KNW N/A
- Revenue
- ACXP N/A
- KNW N/A
- Revenue This Year
- ACXP N/A
- KNW N/A
- Revenue Next Year
- ACXP N/A
- KNW N/A
- P/E Ratio
- ACXP N/A
- KNW N/A
- Revenue Growth
- ACXP N/A
- KNW N/A
- 52 Week Low
- ACXP $1.52
- KNW $0.18
- 52 Week High
- ACXP $5.70
- KNW $0.94
- Technical
- Relative Strength Index (RSI)
- ACXP 42.21
- KNW 27.41
- Support Level
- ACXP $1.99
- KNW $0.18
- Resistance Level
- ACXP $2.14
- KNW $0.23
- Average True Range (ATR)
- ACXP 0.10
- KNW 0.02
- MACD
- ACXP -0.01
- KNW -0.01
- Stochastic Oscillator
- ACXP 22.58
- KNW 11.58
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About KNW Know Labs Inc.
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.